 AnaptysBio Inc NASDAQ: ANAB has announced updated data from the GALLOP Phase 2 trial of imsidolimab in generalized pustular psoriasis GPP. GPP is a rare and extreme form of psoriasis characterized by the presence of sterile pustules. 